Rik Schots
- Hematology top 1%
- Multiple Myeloma Research and Treatments 26
- Hematopoietic Stem Cell Transplantation 12
- Acute Myeloid Leukemia Research 5
- Genetics top 5%
- Immunology top 10%
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 4
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 5
- Oncology top 10%
-
- Protein Degradation and Inhibitors 6
-
- Hematological disorders and diagnostics 4
- Co-authors
- Ivan Van RietM. De WaeleB Van CampC. DemanetPatrick LacorEline MenuKarin VanderkerkenElke De Bruyne
- Cited by
- HematologyGeneticsImmunology
- Journals
- European Journal Of Haematology (6 papers)Blood (6 papers)British Journal of Haematology (5 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Rik Schots
63 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Hematology 779
- Genetics 228
- Immunology 416
- Immunology and Allergy 94
- Oncology 403
Countries citing papers authored by Rik Schots
This map shows the geographic impact of Rik Schots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rik Schots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rik Schots more than expected).
Fields of papers citing papers by Rik Schots
This network shows the impact of papers produced by Rik Schots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rik Schots. The network helps show where Rik Schots may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rik Schots, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 11 | |
| 2 | 2018 | 1 | |
| 3 | 2018 | 125 | |
| 4 | The Future of Access to Innovative Medicines in Cancer Therapy: Towards Conditional Dialogue Fostering Affordable Therapeutic Innovation | 2016 | 3 |
| 5 | 2014 | 17 | |
| 6 | 2012 | 14 | |
| 7 | 2012 | 42 | |
| 8 | 2007 | 31 | |
| 9 | 2005 | 111 | |
| 10 | 2002 | 43 | |
| 11 | 2001 | 17 | |
| 12 | 2001 | 3 | |
| 13 | 2000 | 11 | |
| 14 | 1999 | 33 | |
| 15 | 1999 | 34 | |
| 16 | 1998 | 24 | |
| 17 | 1998 | 42 | |
| 18 | 1997 | 23 | |
| 19 | 1991 | 90 | |
| 20 | 1990 | 2 |
About Rik Schots
Rik Schots is a scholar working on Hematology, Genetics, Immunology and Allergy, Immunology and Emergency Medicine, having authored 63 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Hematopoietic Stem Cell Transplantation (12 papers), Immune Cell Function and Interaction (10 papers), Protein Degradation and Inhibitors (6 papers), Acute Myeloid Leukemia Research (5 papers), Cell Adhesion Molecules Research (5 papers), Immunotherapy and Immune Responses (4 papers) and Hematological disorders and diagnostics (4 papers). The work is most often cited by research in Hematology (779 citations), Genetics (228 citations), Immunology (416 citations), Immunology and Allergy (94 citations) and Oncology (403 citations). Rik Schots has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Ivan Van Riet, M. De Waele, B Van Camp, C. Demanet, Patrick Lacor, Eline Menu, Karin Vanderkerken, Elke De Bruyne, Sonja Verheyden and L. Kaufman. Their work appears in journals such as European Journal Of Haematology, Blood, British Journal of Haematology, Bone Marrow Transplantation and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.